Effect of intrauterine growth retardation on liver and long-term metabolic risk

International Journal of Obesity

Volumn 36, Issue 10, 2012, Pages 1270-1277

  Cianfarani, S ^a   Agostoni, C ^b   Bedogni, G ^c   Berni Canani, R ^d   Brambilla, P ^e   Nobili, V ^f   Pietrobelli, A ^g,h  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Clinical Epidemiology Unit Liver Research Center   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e ASL Milano 2   (Italy)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^g UNIVERSITY OF VERONA   (Italy)

^h PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Cardiometabolic disease; Intrauterine growth retardation (IUGR); Non alcoholic fatty liver disease (NAFLD); Programming; Type 2 diabetes

Indexed keywords

ANIMAL; CARDIOVASCULAR DISEASE; DISEASE MODEL; DISEASE PREDISPOSITION; FATTY LIVER; FEMALE; GENETIC EPIGENESIS; GENETICS; GENOME IMPRINTING; HUMAN; INTRAUTERINE GROWTH RETARDATION; LIVER; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PATHOLOGY; PREGNANCY; PRENATAL EXPOSURE; RAT; REVIEW; RISK FACTOR; SKELETAL MUSCLE;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; EPIGENESIS, GENETIC; FATTY LIVER; FEMALE; FETAL GROWTH RETARDATION; GENOMIC IMPRINTING; HUMANS; ISLETS OF LANGERHANS; LIVER; MALE; MUSCLE, SKELETAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RISK FACTORS;

EID: 84873954128     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.54     Document Type: Article

References (114)

1. Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986; 1: 1077–1081.
2. Barker D, Winter P, Osmond C, Margetts B, Simmonds S. Weight in infancy and death from ischaemic heart disease. Lancet 1989; 2: 577–580.
3. Hales C, Barker D. Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia 1992; 35: 595–601.
4. Hales C, Barker D. The thrifty phenotype hypothesis. Br Med Bull 2001; 60: 5–20.
5. Fowden A, Giussani D, Forhead A. Intrauterine programming of physiological systems: Causes and consequences. Physiology (Bethesda) 2006; 21: 29–37.
6. Barker DJ. The fetal and infant origins of adult disease. BMJ 1990; 301: 1111.
7. Godfrey K, Lillycrop K, Burdge G, Gluckman P, Hanson M. Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease. Pediatr Res 2007; 61: 5R–10R.
8. Cianfarani S, Germani D, Branca F. Low birthweight and adult insulin resistance: the "catch-up growth" hypothesis. Arch Dis Child Fetal Neonatal Ed 1999; 81: F71–F73.
9. Ozanne SE, Hales CN. Lifespan: Catch-up growth and obesity in male mice. Nature 2004; 427: 411–412.
10. Gluckman P, Hanson M. Living with the past: Evolution, development, and patterns of disease. Science 2004; 305: 1733–1736.
11. Canani RB, Di Costanzo M, Leone L, Bedogni G, Brambilla P, Cianfarani S, Epigenetic mechanisms elicited by nutrition in early life. Nutr Res Rev 2011 1–8.
12. Gluckman P, Hanson M, Bateson P, Beedle A, Law C, Bhutta Z, Towards a new developmental synthesis: Adaptive developmental plasticity and human disease. Lancet 2009; 373: 1654–1657.
13. Morris TJ, Vickers M, Gluckman P, Gilmour S, Affara N. Transcriptional profiling of rats subjected to gestational undernourishment: Implications for the developmental variations in metabolic traits. PLoS One 2009; 4: E7271.
14. Puglianiello A, Germani D, Antignani S, Tomba GS, Cianfarani S. Changes in the expression of hypothalamic lipid sensing genes in rat model of intrauterine growth retardation (IUGR). Pediatr Res 2007; 61: 433–437.
15. Ritz E, Amann K, Koleganova N, Benz K. Prenatal programming-effects on blood pressure and renal function. Nat Rev Nephrol 2011; 7: 137–144.
16. Moritz KM, Singh RR, Probyn ME, Denton KM. Developmental programming of a reduced nephron endowment: More than just a baby’s birth weight. Am J Physiol Renal Physiol 2009; 296: F1–F9.
17. Gingery A, Soldner EL, Heltemes A, Nelson A, Bozadjieva N. Developmental programming of the kidney: Does sex matter? J Physiol 2009; 587: 5521–5522.
18. Langley-Evans SC, Welham SJ, Jackson AA. Fetal exposure to a maternal low protein diet impairs nephrogenesis and promotes hypertension in the rat Life Sci 1999; 64: 965–974.
19. Gluckman P, Hanson M, Buklijas T, Low F, Beedle A. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat Rev Endocrinol 2009; 5: 401–408.
20. Pinney S, Simmons R. Epigenetic mechanisms in the development of type 2 diabetes. Trends Endocrinol Metab 2010; 21: 223–229.
21. Goldberg A, Allis C, Bernstein E. Epigenetics: A landscape takes shape. Cell 2007; 128: 635–638.
22. Fu Q, McKnight R, Yu X, Wang L, Callaway C, Lane R. Uteroplacental insufficiency induces site-specific changes in histone H3 covalent modifications and affects DNAhistone H3 positioning in day 0 IUGR rat liver. Physiol Genomics 2004; 20: 108–116.
23. Park J, Stoffers D, Nicholls R, Simmons R. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest 2008; 118: 2316–2324.
24. Raychaudhuri N, Raychaudhuri S, Thamotharan M, Devaskar S. Histone code modifications repress glucose transporter 4 expression in the intrauterine growth-restricted offspring. J Biol Chem 2008; 283: 13611–13626.
25. Thompson R, Fazzari M, Niu H, Barzilai N, Simmons R, Greally J. Experimental intrauterine growth restriction induces alterations in DNA methylation and gene expression in pancreatic islets of rats. J Biol Chem 2010; 285: 15111–15118.
26. MacLennan N, James S, Melnyk S, Piroozi A, Jernigan S, Hsu J, Uteroplacental insufficiency alters DNA methylation, one-carbon metabolism, and histone acetylation in IUGR rats. Physiol Genomics 2004; 18: 43–50.
27. Lane R, Kelley D, Gruetzmacher E, Devaskar S. Uteroplacental insufficiency alters hepatic fatty acid-metabolizing enzymes in juvenile and adult rats. Am J Physiol Regul Integr Comp Physiol 2001; 280: R183–R190.
28. Lane R, MacLennan N, Hsu J, Janke S, Pham T. Increased hepatic peroxisome proliferator-activated receptor-gamma coactivator-1 gene expression in a rat model of intrauterine growth retardation and subsequent insulin resistance. Endocrinology 2002; 143: 2486–2490.
29. Yoon J, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001; 413: 131–138.
30. McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system-from concept to molecular analysis. Eur J Biochem 1997; 244: 1–14.
31. Cianfarani S. Foetal origins of adult diseases: Just a matter of stem cell number? Med Hypotheses 2003; 61: 401–404.
32. Fowden AL, Giussani DA, Forhead AJ. Endocrine and metabolic programming during intrauterine development. Early Hum Dev 2005; 81: 723–734.
33. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: Prediction, plasticity, and programming. Physiol Rev 2005; 85: 571–633.
34. Lumey L, Stein A, Kahn H, Van Der Pal-De Bruin K, Blauw G, Zybert P, Cohort profile: The Dutch Hunger Winter families study. Int J Epidemiol 2007; 36: 1196–1204.
35. Heijmans B, Tobi E, Stein A, Putter H, Blauw G, Susser E, Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA 2008; 105: 17046–17049.
36. Steegers-Theunissen R, Obermann-Borst S, Kremer D, Lindemans J, Siebel C, Steegers E, Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child PLoS One 2009; 4: E7845.
37. Stein A, Lumey L. The relationship between maternal and offspring birth weights after maternal prenatal famine exposure: The Dutch Famine Birth Cohort Study. Hum Biol 2000; 72: 641–654.
38. Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab 2010; 21: 214–222.
39. Crews D, Gore AC, Hsu TS, Dangleben NL, Spinetta M, Schallert T, Transgenerational epigenetic imprints on mate preference. Proc Natl Acad Sci USA 2007; 104: 5942–5946.
40. Seckl JR, Holmes MC. Mechanisms of disease: Glucocorticoids, their placental metabolism and fetal’programming’ of adult pathophysiology. Nat Clin Pract Endocrinol Metab 2007; 3: 479–488.
41. Doyle LW, Ford GW, Davis NM, Callanan C. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci (Lond) 2000; 98: 137–142.
42. Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A, Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 2005; 365: 1856–1862.
43. de Vries A, Holmes MC, Heijnis A, Seier JV, Heerden J, Louw J, Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function. J Clin Invest 2007; 117: 1058–1067.
44. Cianfarani S, Geremia C, Scott CD, Growth Germani D. IGF system, and cortisol in children with intrauterine growth retardation: Is catch-up growth affected by reprogramming of the hypothalamic-pituitary-adrenal axis? Pediatr Res 2002; 51: 94–99.
45. Phillips DI, Barker DJ, Fall CH, Seckl JR, Whorwood CB, Wood PJ, Elevated plasma cortisol concentrations: A link between low birth weight and the insulin resistance syndrome? J Clin Endocrinol Metab 1998; 83: 757–760.
46. Phillips DI, Walker BR, Reynolds RM, Flanagan DE, Wood PJ, Osmond C, Low birth weight predicts elevated plasma cortisol concentrations in adults from 3 populations. Hypertension 2000; 35: 1301–1306.
47. Reynolds RM, Walker BR, Syddall HE, Andrew R, Wood PJ, Whorwood CB, Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J Clin Endocrinol Metab 2001; 86: 245–250.
48. Buhl ES, Neschen S, Yonemitsu S, Rossbacher J, Zhang D, Morino K, Increased hypothalamic-pituitary-adrenal axis activity and hepatic insulin resistance in low-birth-weight rats. Am J Physiol Endocrinol Metab 2007; 293: E1451–E1458.
49. Berkowitz GS, Wolff MS, Janevic TM, Holzman IR, Yehuda R, Landrigan PJ. The World Trade Center disaster and intrauterine growth restriction. JAMA 2003; 290: 595–596.
50. Filiberto AC, Maccani MA, Koestler D, Wilhelm-Benartzi C, Avissar-Whiting M, Banister CE, Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta. Epigenetics 2011; 6: 566–572.
51. Lane RH, Flozak AS, Ogata ES, Bell GI, Simmons RA. Altered hepatic gene expression of enzymes involved in energy metabolism in the growth-retarded fetal rat. Pediatr Res 1996; 39: 390–394.
52. Ogata ES, Swanson SL, Collins JW, Finley SL. Intrauterine growth retardation: altered hepatic energy and redox states in the fetal rat. Pediatr Res 1990; 27: 56–63.
53. Lane RH, Crawford SE, Flozak AS, Simmons RA. Localization and quantification of glucose transporters in liver of growth-retarded fetal and neonatal rats. Am J Physiol 1999; 276: E135–E142.
54. Germani D, Puglianiello A, Cianfarani S. Uteroplacental insufficiency down regulates insulin receptor and affects expression of key enzymes of long-chain fatty acid (LCFA) metabolism in skeletal muscle at birth. Cardiovasc Diabetol 2008; 7: 14.
55. Puglianiello A, Germani D, Cianfarani S. Exposure to uteroplacental insufficiency reduces the expression of signal transducer and activator of transcription 3 and proopiomelanocortin in the hypothalamus of newborn rats. Pediatr Res 2009; 66: 208–211.
56. Moon S, Kim JH, Han JH, Ko SH, Ahn YB, Yang SH, Novel compound heterozygous mutations in the fructose-1, 6-bisphosphatase gene cause hypoglycemia and lactic acidosis. Metabolism 2011; 60: 107–113.
57. Jiang MH, Fei J, Lan MS, Lu ZP, Liu M, Fan WW, Hypermethylation of hepatic Gck promoter in ageing rats contributes to diabetogenic potential. Diabetologia 2008; 51: 1525–1533.
58. Harding JW, Pyeritz EA, Copeland ES, White HB. Role of glycerol 3-phosphate dehydrogenase in glyceride metabolism. Effect of diet on enzyme activities in chicken liver. Biochem J 1975; 146: 223–229.
59. Moreno F, Herrero P. The hexokinase 2-dependent glucose signal transduction pathway of Saccharomyces cerevisiae. FEMS Microbiol Rev 2002; 26: 83–90.
60. Manco L, Ribeiro ML. Novel human pathological mutations. Gene symbol: Pklr. Disease: Pyruvate kinase deficiency. Hum Genet 2009; 125: 343.
61. Olson AL, Pessin JE. Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annu Rev Nutr 1996; 16: 235–256.
62. Huang J, Jia Y, Fu T, Viswakarma N, Bai L, Rao MS, Sustained activation of PPAR(alpha) by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J 2011; 26: 628–638.
63. Simmons R, Templeton L, Gertz S. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 2001; 50: 2279–2286.
64. Burns SP, Desai M, Cohen RD, Hales CN, Iles RA, Germain JP, Gluconeogenesis, glucose handling, and structural changes in livers of the adult offspring of rats partially deprived of protein during pregnancy and lactation. J Clin Invest 1997; 100: 1768–1774.
65. Desai M, Byrne CD, Zhang J, Petry CJ, Lucas A, Hales CN. Programming of hepatic insulin-sensitive enzymes in offspring of rat dams fed a protein-restricted diet. Am J Physiol 1997; 272: G1083–G1090.
66. Desai M, Byrne CD, Meeran K, Martenz ND, Bloom SR, Hales CN. Regulation of hepatic enzymes and insulin levels in offspring of rat dams fed a reducedprotein diet. Am J Physiol 1997; 273: G899–G904.
67. Vaiman D, Gascoin-Lachambre G, Boubred F, Mondon F, Feuerstein JM, Ligi I, The intensity of IUGR-induced transcriptome deregulations is inversely correlated with the onset of organ function in a rat model. PLoS One 2011; 6: e21222.
68. Camm EJ, Martin-Gronert MS, Wright NL, Hansell JA, Ozanne SE, Giussani DA. Prenatal hypoxia independent of undernutrition promotes molecular markers of insulin resistance in adult offspring. FASEB J 2011; 25: 420–427.
69. Drake AJ, Reynolds RM. Impact of maternal obesity on offspring obesity and cardiometabolic disease risk. Reproduction 2010; 140: 387–398.
70. Gregorio BM, Souza-Mello V, Carvalho JJ, Mandarim-de-Lacerda CA, Aguila MB. Maternal high-fat intake predisposes nonalcoholic fatty liver disease in C57BL/6 offspring. Am J Obstet Gynecol 2010; 203: 495.e1–495.e8.
71. Bruce KD, Cagampang FR, Argenton M, Zhang J, Ethirajan PL, Burdge GC, Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression. Hepatology 2009; 50: 1796–1808.
72. Strakovsky RS, Zhang X, Zhou D, Pan YX. Gestational high fat diet programs hepatic phosphoenolpyruvate carboxykinase (Pck) expression and histone modification in neonatal offspring rats. J Physiol 2011; 589: 2707–2717.
73. Oster M, Murani E, Metges CC, Ponsuksili S, Wimmers K. A high protein diet during pregnancy affects hepatic gene expression of energy sensing pathways along ontogenesis in a porcine model. PLoS One 2011; 6: E21691.
74. Yamashita H, Shao J, Qiao L, Pagliassotti M, Friedman JE. Effect of spontaneous gestational diabetes on fetal and postnatal hepatic insulin resistance in Lepr(db/þ) mice. Pediatr Res 2003; 53: 411–418.
75. Mulay S, Philip A, Solomon S. Influence of maternal diabetes on fetal rat development: Alteration of insulin receptors in fetal liver and lung. J Endocrinol 1983; 98: 401–410.
76. Barker DJ, Meade TW, Fall CH, Lee A, Osmond C, Phipps K, Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. BMJ 1992; 304: 148–152.
77. Barker DJ, Martyn CN, Osmond C, Hales CN, Fall CH. Growth in utero and serum cholesterol concentrations in adult life. BMJ 1993; 307: 1524–1527.
78. Barker DJ, Martyn CN, Osmond C, Wield GA. Abnormal liver growth in utero and death from coronary heart disease. BMJ 1995; 310: 703–704.
79. Barker DJ, Hanson MA. Altered regional blood flow in the fetus: The origins of cardiovascular disease? Acta Paediatr 2004; 93: 1559–1560.
80. Latini G, De Mitri B, Del Vecchio A, Chitano G, De Felice C, Zetterström R Foetal growth of kidneys, liver and spleen in intrauterine growth restriction: "programming" causing "metabolic syndrome" in adult age. Acta Paediatr 2004; 93: 1635–1639.
81. Cetin I, Giovannini N, Alvino G, Agostoni C, Riva E, Giovannini M, Intrauterine growth restriction is associated with changes in polyunsaturated fatty acid fetalmaternal relationships. Pediatr Res 2002; 52: 750–755.
82. Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, Beilin LJ. Dietary fish as a major component of a weight-loss diet: Effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 1999; 70: 817–825.
83. Couet C, Delarue J, Ritz P, Antoine JM, Lamisse F. Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes Relat Metab Disord 1997; 21: 637–643.
84. Jelenik T, Rossmeisl M, Kuda O, Jilkova ZM, Medrikova D, Kus V, AMPactivated protein kinase a2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids. Diabetes 2010; 59: 2737–2746.
85. Kuda O, Jelenik T, Jilkova Z, Flachs P, Rossmeisl M, Hensler M, N-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Diabetologia 2009; 52: 941–951.
86. Riediger ND, Othman RA, Suh M, Moghadasian MH. A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 2009; 109: 668–679.
87. Simon JA, Hodgkins ML, Browner WS, Neuhaus JM, Bernert JT, Hulley SB. Serum fatty acids and the risk of coronary heart disease. Am J Epidemiol 1995; 142: 469–476.
88. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002; 346: 1113–1118.
89. Lindqvist HM, Sandberg AS, Fagerberg B, Hulthe J. Plasma phospholipid EPA and DHA in relation to atherosclerosis in 61-year-old men. Atherosclerosis 2009; 205: 574–578.
90. Labayen I, Moreno LA, Ruiz JR, Ortega FB, Sjostrom M, Huybrechts I, Associations of birth weight with serum long chain polyunsaturated fatty acids in adolescents; the HELENA study. Atherosclerosis 2011; 217: 286–291.
91. Agostoni C. Role of long-chain polyunsaturated fatty acids in the first year of life. J Pediatr Gastroenterol Nutr 2008; 47(2): S41–S44.
92. Das UN. A perinatal strategy to prevent coronary heart disease. Nutrition 2003; 19: 1022–1027.
93. Singhal A, Cole TJ, Lucas A. Early nutrition in preterm infants and later blood pressure: Two cohorts after randomised trials. Lancet 2001; 357: 413–419.
94. Singhal A, Cole TJ, Fewtrell M, Lucas A. Breastmilk feeding and lipoprotein profile in adolescents born preterm: Follow-up of a prospective randomised study. Lancet 2004; 363: 1571–1578.
95. Martin RM, Davey Smith G. Does having been breastfed in infancy influence lipid profile in later life?: A review of the literature. Adv Exp Med Biol 2009; 646: 41–50.
96. Singhal A, Fewtrell M, Cole TJ, Lucas A. Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet 2003; 361: 1089–1097.
97. Nobili V, Bedogni G, Alisi A, Pietrobattista A, Risè P, Galli C, Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: Double-blind randomised controlled clinical trial. Arch Dis Child 2011; 96: 350–353.
98. Jensen CB, Storgaard H, Dela F, Holst JJ, Madsbad S, Vaag AA. Early differential defects of insulin secretion and action in 19-year-old caucasian men who had low birth weight. Diabetes 2002; 51: 1271–1280.
99. Arenz S, Rü ckerl R, Koletzko B, von Kries R. Breast-feeding and childhood obesity-a systematic review. Int J Obes Relat Metab Disord 2004; 28: 1247–1256.
100. Martin RM, Gunnell D, Smith GD. Breastfeeding in infancy and blood pressure in later life: Systematic review and meta-analysis. Am J Epidemiol 2005; 161: 15–26.
101. Owen CG, Martin RM, Whincup PH, Smith GD, Cook DG. Does breastfeeding influence risk of type 2 diabetes in later life? A quantitative analysis of published evidence. Am J Clin Nutr 2006; 84: 1043–1054.
102. Owen CG, Whincup PH, Kaye SJ, Martin RM, Davey Smith G, Cook DG, Does initial breastfeeding lead to lower blood cholesterol in adult life? A quantitative review of the evidence. Am J Clin Nutr 2008; 88: 305–314.
103. Nobili V, Bedogni G, Alisi A, Pietrobattista A, Alterio A, Tiribelli C, A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease. Arch Dis Child 2009; 94: 801–805.
104. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: From pathophysiology to prevention and management. Lancet 2011; 378: 169–181.
105. Smith BW, Adams LA. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol 2011; 7: 456–465.
106. Nobili V, Marcellini M, Marchesini G, Vanni E, Manco M, Villani A, Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. Diabetes Care 2007; 30: 2638–2640.
107. Leunissen RW, Kerkhof GF, Stijnen T, Hokken-Koelega A. Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. JAMA 2009; 301: 2234–2242.
108. Barker D, Osmond C, Forsén T, Kajantie E, Eriksson J. Trajectories of growth among children who have coronary events as adults. N Engl J Med 2005; 353: 1802–1809.
109. Widdowson EM, Crabb DE, Milner RD. Cellular development of some human organs before birth. Arch Dis Child 1972; 47: 652–655.
110. Hochberg Z, Feil R, Constancia M, Fraga M, Junien C, Carel JC, Child health, developmental plasticity, and epigenetic programming. Endocr Rev 2011; 32: 159–224.
111. Vickers M, Gluckman P, Coveny A, Hofman P, Cutfield W, Gertler A, Neonatal leptin treatment reverses developmental programming. Endocrinology 2005; 146: 4211–4216.
112. Burdge GC, Lillycrop KA, Phillips ES, Slater-Jefferies JL, Jackson AA, Hanson MA. Folic acid supplementation during the juvenile-pubertal period in rats modifies the phenotype and epigenotype induced by prenatal nutrition. J Nutr 2009; 139: 1054–1060.
113. Wiedmeier JE, Joss-Moore LA, Lane RH, Neu J. Early postnatal nutrition and programming of the preterm neonate. Nutr Rev 2011; 69: 76–82.
114. Choi SW, Friso S, Epigenetics A. New Bridge between nutrition and health. Adv Nutr (Bethesda) 2010; 1: 8–16.